Baltimore, MD, United States of America

Gary R Pasternack

This inventor holds 31 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 2 EPO patents, primarily in Bacteriophage Applications. Top assignees: Intralytix, Inc., Johns Hopkins University, Asklepion Pharmaceuticals, LLC. Active years: 1997-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gary R Pasternack. Retrieved from https://idiyas.com/inventor/gary-r-pasternack

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 31 

% Patents Active = 90.3

 

 

Average Co-Inventor Count = 2.0

ph-index = 10

Forward Citations = 392(Granted Patents)


Company Filing History:


Years Active: 1997-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Bacteriophage
Antimicrobial Compounds
Endothelial Dysfunction
Salmonella
Cancer Related Antigen
Tissue Samples
Nucleic Acid
Cell Division
Fatty Acid Synthase
Gene Family
Protein Assays
Sanitation
31 patents (USPTO):Explore Patents

Title: Gary R. Pasternack: Innovator in Bacteriophage Research

Introduction: Gary R. Pasternack is a prominent inventor based in Baltimore, MD, known for his extensive contributions to the field of bacteriophage research. With an impressive portfolio of 30 patents, Pasternack has dedicated his career to developing innovative solutions aimed at combating bacterial infections and enhancing food safety.

Latest Patents: Two of Pasternack’s latest significant patents include innovations related to bacteriophages. The first patent focuses on isolated bacteriophages that exhibit specificity and lytic activity against certain strains, presenting methods for their use to control bacterial growth in various environments such as food safety, sanitation, and microbiome modulation. The second patent centers on Salmonella bacteriophages, emphasizing their targeted activity and potential applications in similar settings, promoting the development of probiotics and ensuring greater public health safety.

Career Highlights: Throughout his career, Gary R. Pasternack has played key roles in influential companies and research institutions, including Intralytix, Inc. and The Johns Hopkins University. His innovative work has positioned him as a leader in bacteriophage technology and its application in real-world scenarios.

Collaborations: Pasternack has collaborated with notable professionals in the field, including Alexander Sulakvelidze and Francis P. Kuhajda. These partnerships have fostered significant advancements and contributions to bacteriophage research, further strengthening the impact of his work on the scientific community.

Conclusion: Gary R. Pasternack's dedication to innovation in bacteriophage research has marked him as an important figure in his field. With a considerable number of patents to his name and noteworthy collaborations, Pasternack continues to influence advancements in food safety and bacterial control methods, showcasing the potential of bacteriophages in modern health solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…